bioMérieux: FY earnings up 8%
(CercleFinance.com) - bioMérieux announces 2018 consolidated net income of 257 million euros, up 8.
3%, with underlying current operating income of 361 million euros, compared with 335 million euros in 2017, representing a 0.3-point improvement in its margin to 14.9%.
Revenues of the in vitro diagnostics specialist reached 2,421 million euros, up 5.8% as reported, and up 9.9% on a like-for-like basis, slightly exceeding the group's target of around 9.5%.
bioMérieux proposes a dividend of 0.35 euro per share for 2018 and in 2019 targets organic sales growth of between 7% and 8.5%, at constant exchange rates and consolidation scope, as well as underlying operating profit of between 385 million and 400 million euros.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
3%, with underlying current operating income of 361 million euros, compared with 335 million euros in 2017, representing a 0.3-point improvement in its margin to 14.9%.
Revenues of the in vitro diagnostics specialist reached 2,421 million euros, up 5.8% as reported, and up 9.9% on a like-for-like basis, slightly exceeding the group's target of around 9.5%.
bioMérieux proposes a dividend of 0.35 euro per share for 2018 and in 2019 targets organic sales growth of between 7% and 8.5%, at constant exchange rates and consolidation scope, as well as underlying operating profit of between 385 million and 400 million euros.
Copyright (c) 2019 CercleFinance.com. All rights reserved.